Atea Pharmaceuticals, Inc. (AVIR): A Bull Case Theory

We came across a bullish thesis on Atea Pharmaceuticals, Inc. (AVIR) on Substack by Turtles Research. In this article, we will summarize the bulls’ thesis on AVIR. Atea Pharmaceuticals, Inc. (AVIR)'s share was trading at $3.15 as of March 20^th.

[caption id="attachment_1238870" align="aligncenter" width="768"] A clinical researcher in a lab examining a new biopharmaceutical product.[/caption]

Atea Pharmaceuticals (AVIR) is at a critical juncture, with three activist investors—BML, Tang, and Bradley L. Radoff—pushing for change. These investors, who collectively own nearly 20%...